4340 East Kentucky Avenue
Suite 206
Glendale, CO 80246
United States
303 495 7583
https://www.nexienbiopharma.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Richard S. Greenberg | Founder, CEO, Executive VP & Chairman | N/A | N/A | 1949 |
Mr. Evan L. Wasoff CPA | Chief Financial Officer | N/A | N/A | 1948 |
Mr. Robert I. Goldfarb J.D., Esq. | Chief Operating Officer | 55k | N/A | 1956 |
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
Nexien BioPharma, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.